Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects

Autor: Caterina Scuderi, Maria Rosanna Bronzuoli, Roberta Facchinetti, Lorenzo Pace, Luca Ferraro, Kevin Donald Broad, Gaetano Serviddio, Francesco Bellanti, Gianmauro Palombelli, Giulia Carpinelli, Rossella Canese, Silvana Gaetani, Luca Steardo, Tommaso Cassano
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
Magnetic Resonance Spectroscopy
Microdialysis
Anti-Inflammatory Agents
Hippocampus
Palmitic Acidstau Proteins
129 Strain
Inbred C57BL
Transgenic
chemistry.chemical_compound
Mice
0302 clinical medicine
Hippocampal
3×Tg-AD mice
Behavior
Animal

Neurodegeneration
Age Factors
food and beverages
Alzheimer's disease
palmitoylethanolamide
astrocyte
MRI/MRS
Magnetic Resonance Imaging
Psychiatry and Mental health
Neuroprotective Agents
Ethanolamines
Mice
129 Strain

Context (language use)
Mice
Transgenic

tau Proteins
Palmitic Acids
Neuroprotection
Article
NO
lcsh:RC321-571
03 medical and health sciences
Cellular and Molecular Neuroscience
Neurochemical
Alzheimer Disease
medicine
Animals
Learning
Cognitive Dysfunction
CA1 Region
Hippocampal

lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
Biological Psychiatry
Neuroinflammation
Inflammation
Behavior
Palmitoylethanolamide
Memory Disorders
Amyloid beta-Peptides
Animal
business.industry
medicine.disease
Symptomatic relief
Amides
Mice
Inbred C57BL

Disease Models
Animal

030104 developmental biology
chemistry
Disease Models
Age Factors
Alzheimer Disease
Amyloid beta-Peptides
Animals
Anti-Inflammatory Agents
Behavior
AnimalCA1 Region
Hippocampal
Cognitive Dysfunction
Disease Models
Animal
Ethanolamines
Inflammation
Learning
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Memory Disorders
Mice
Mice
129 Strain
Mice
Inbred C57BL
Mice
Transgenic
Microdialysis
Neuroprotective Agents
Palmitic Acidstau Proteins

AnimalCA1 Region
business
Neuroscience
030217 neurology & neurosurgery
Zdroj: Translational Psychiatry, Vol 8, Iss 1, Pp 1-19 (2018)
Translational Psychiatry
ISSN: 2158-3188
DOI: 10.1038/s41398-017-0076-4
Popis: In an aging society, Alzheimer’s disease (AD) exerts an increasingly serious health and economic burden. Current treatments provide inadequate symptomatic relief as several distinct pathological processes are thought to underlie the decline of cognitive and neural function seen in AD. This suggests that the efficacy of treatment requires a multitargeted approach. In this context, palmitoylethanolamide (PEA) provides a novel potential adjunct therapy that can be incorporated into a multitargeted treatment strategy. We used young (6-month-old) and adult (12-month-old) 3×Tg-AD mice that received ultramicronized PEA (um-PEA) for 3 months via a subcutaneous delivery system. Mice were tested with a range of cognitive and noncognitive tasks, scanned with magnetic resonance imaging/magnetic resonance spectroscopy (MRI/MRS), and neurochemical release was assessed by microdialysis. Potential neuropathological mechanisms were assessed postmortem by western blot, reverse transcription–polymerase chain reaction (RT-PCR), and immunofluorescence. Our data demonstrate that um-PEA improves learning and memory, and ameliorates both the depressive and anhedonia-like phenotype of 3×Tg-AD mice. Moreover, it reduces Aβ formation, the phosphorylation of tau proteins, and promotes neuronal survival in the CA1 subregion of the hippocampus. Finally, um-PEA normalizes astrocytic function, rebalances glutamatergic transmission, and restrains neuroinflammation. The efficacy of um-PEA is particularly potent in younger mice, suggesting its potential as an early treatment. These data demonstrate that um-PEA is a novel and effective promising treatment for AD with the potential to be integrated into a multitargeted treatment strategy in combination with other drugs. Um-PEA is already registered for human use. This, in combination with our data, suggests the potential to rapidly proceed to clinical use.
Databáze: OpenAIRE